Literature DB >> 22001125

Salvianolic acid B and its liposomal formulations: anti-hyperalgesic activity in the treatment of neuropathic pain.

Benedetta Isacchi1, Valentina Fabbri, Nicoletta Galeotti, Maria Camilla Bergonzi, Anastasia Karioti, Carla Ghelardini, Maria Giuliana Vannucchi, Anna Rita Bilia.   

Abstract

Salvianolic acid B (SalB) represents the most characteristic constituent of Salvia miltiorrhiza Bge. with a strong free radicals scavenger activity. This property may be useful in the treatment of some severe chronic diseases, where there is an imbalance of reactive oxygen species formation and where intracellular reactive oxygen and nitrogen species level can cause severe cell damage and even cell death. In particular, SalB can protect against the oxidative stress as well as the antioxidant superoxide dismutase and reduced activity of glutathione, important determinants of neuropathological and behavioural consequences in neuropathic pain. This is a chronic disease defined by the WHO as an untreatable illness because therapeutics are unsatisfactory in many cases and there is an urgent need to discover and develop novel active drugs. In the present work, SalB has been extracted and purified with an efficient and rapid method from the roots and rhizome of S. miltiorrhiza Bge. It was firstly submitted to pharmacological studies using the paw-pressure test, in an animal model of neuropathic pain where a peripheral mono neuropathy was produced by a chronic constriction injury of the sciatic nerve. SalB was effective against mechanical hyperalgesia when administered intraperitoneally at the dose of 100mg/kg, 15 min after administration. Due to the poor chemical stability and bioavailability of SalB, liposomes were developed as drug carriers for parental administration. SalB-loaded liposomes were characterised in terms of particle size, polydispersity index, encapsulation efficacy and morphology. According to the in vivo studies, encapsulation, especially into PEGylated liposomes, increased and prolonged the antihyperalgesic activity 30 min after i.p. administration and the effect was still significant at 45 min. Thus, PEGylated formulation ameliorated the performance of drug delaying, increasing and prolonging in time its antihyperalgesic effect. Copyright Â
© 2011 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22001125     DOI: 10.1016/j.ejps.2011.09.019

Source DB:  PubMed          Journal:  Eur J Pharm Sci        ISSN: 0928-0987            Impact factor:   4.384


  13 in total

1.  Effects of salvianolic acid B on in vitro growth inhibition and apoptosis induction of retinoblastoma cells.

Authors:  Xing-An Liu
Journal:  Int J Ophthalmol       Date:  2012-06-18       Impact factor: 1.779

2.  Cardiomyocyte-like cells differentiation from non β-catenin expression mesenchymal stem cells.

Authors:  Qing Gao; Xiantong Hu; Xijuan Jiang; Maojuan Guo; Hong Ji; Yijing Wang; Yingchang Fan
Journal:  Cytotechnology       Date:  2014-04-11       Impact factor: 2.058

3.  Analgesic effect of piracetam on peripheral neuropathic pain induced by chronic constriction injury of sciatic nerve in rats.

Authors:  Ashish K Mehta; Yogendra Bhati; Chakra D Tripathi; Krishna K Sharma
Journal:  Neurochem Res       Date:  2014-05-16       Impact factor: 3.996

Review 4.  Mesenchymal Stem Cells for Cardiac Regeneration: from Differentiation to Cell Delivery.

Authors:  Santosh Gupta; Akriti Sharma; Archana S; Rama Shanker Verma
Journal:  Stem Cell Rev Rep       Date:  2021-05-05       Impact factor: 5.739

5.  Anti-Inflammatory and Antihyperalgesic Activities of Ethanolic Extract and Fruticulin A from Salvia lachnostachys Leaves in Mice.

Authors:  Ana Claudia Piccinelli; Diana Figueiredo de Santana Aquino; Priscila Neder Morato; Angela Midori Kuraoka-Oliveira; Regiane Lauriano Batista Strapasson; Elide Pereira Dos Santos; Maria Élida Alves Stefanello; Rodrigo Juliano Oliveira; Cândida Aparecida Leite Kassuya
Journal:  Evid Based Complement Alternat Med       Date:  2014-11-10       Impact factor: 2.629

6.  Development and Percutaneous Permeation Study of Escinosomes, Escin-Based Nanovesicles Loaded with Berberine Chloride.

Authors:  Giulia Vanti; Daniele Bani; Maria Cristina Salvatici; Maria Camilla Bergonzi; Anna Rita Bilia
Journal:  Pharmaceutics       Date:  2019-12-15       Impact factor: 6.321

7.  Inhibitory Effect of Lithospermic Acid on the HIV-1 Nucleocapsid Protein.

Authors:  Mattia Mori; Stefano Ciaco; Yves Mély; Anastasia Karioti
Journal:  Molecules       Date:  2020-11-20       Impact factor: 4.411

8.  Identifying Chinese herbal medicine for premenstrual syndrome: implications from a nationwide database.

Authors:  Hsing-Yu Chen; Ben-Shian Huang; Yi-Hsuan Lin; Irene H Su; Sien-Hung Yang; Jiun-Liang Chen; Jen-Wu Huang; Yu-Chun Chen
Journal:  BMC Complement Altern Med       Date:  2014-06-27       Impact factor: 3.659

9.  A cocktail method for promoting cardiomyocyte differentiation from bone marrow-derived mesenchymal stem cells.

Authors:  Qing Gao; Maojuan Guo; Xijuan Jiang; Xiantong Hu; Yijing Wang; Yingchang Fan
Journal:  Stem Cells Int       Date:  2014-06-23       Impact factor: 5.443

10.  Glycerosome of Melissa officinalis L. Essential Oil for Effective Anti-HSV Type 1.

Authors:  Giulia Vanti; Sotirios G Ntallis; Christos A Panagiotidis; Virginia Dourdouni; Christina Patsoura; Maria Camilla Bergonzi; Diamanto Lazari; Anna Rita Bilia
Journal:  Molecules       Date:  2020-07-08       Impact factor: 4.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.